Product Name:

JNK2-3


Product Number:

ab-nk189-4

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 2

Target Alias: c-Jun N-terminal kinase 2; JNK2alpha; JNK2-alpha-2; JNK2A; JNK2B; JNK2beta; JNK-55; Jun kinase; Kinase JNK2; MAPK9; MK09; p54a; PRKM9; Stress-activated protein kinase JNK2; JNK-55; SAPK1a; JNK2BETA; p54aSAPK; CCDS4453.1; ENSG00000050748

Product Type Specific: Protein kinase pan-specific antibody

Antibody Code: NK189-4

Antibody Target Type: Pan-specific

Protein UniProt: P45984 

Protein SigNET: P45984 

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human JNK2 (MAPK9) sequence peptide Cat. No.: PE-01AXP90

Antibody Immunogen Sequence: MSDSKGDSQFYSVQVC

Antibody Immunogen Description: Corresponds to amino acid residues M1 to V15; N-terminus

Production Method: Corresponds to amino acid residues M1 to V15; N-terminus

Antibody Modification: Protein kinase pan-specific antibody

Antibody Concentration: 0.24 / 0.25 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 48-54 kDa.

Antibody Specificity: Very high

Antibody Cross Reactivity: No immunoreactivity on protein dot blots with recombinant human JNK1 and JNK3.

Scientific Background: JNK2 (MAPK9) is a protein-serine/threonine kinase of the CMGC group and MAPK family. It is involved in the control of cell differentiation, transformation, migration, proliferation, and programmed cell death in response to stress and cytokines. It has also been implicated in preventing ubiquitination of p53.Phosphorylation of T183 and Y185 by either of two dual specificity kinases, MAP2K4 and MAP2K7, increases phosphotransferase activity. Phosphorylation of S129 also increases phosphotransferase activity. It is nhibited by dual specificity phosphatases, such as DUSP1, which target the T183 and Y185 activatory phosphorylation sites. JNK2 has been shown, in a cancer cell line to have a role in breast cancer cell motility.